Equities

SMS Lifesciences India Ltd

SMSLIFE:NSI

SMS Lifesciences India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,485.00
  • Today's Change-3.65 / -0.25%
  • Shares traded3.93k
  • 1 Year change+183.40%
  • Beta0.9604
Data delayed at least 15 minutes, as of Sep 20 2024 10:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments5.703632
Total Receivables, Net652603576
Total Inventory869920919
Prepaid expenses172422
Other current assets, total9.238.0312
Total current assets1,5531,5911,560
Property, plant & equipment, net2,2932,2911,931
Goodwill, net----0
Intangibles, net0.500.751.14
Long term investments0.360.360.41
Note receivable - long term596575
Other long term assets----0
Total assets3,9053,9493,567
LIABILITIES
Accounts payable591597779
Accrued expenses5.056.694.13
Notes payable/short-term debt468301271
Current portion long-term debt/capital leases184141103
Other current liabilities, total197290197
Total current liabilities1,4461,3361,354
Total long term debt355562422
Total debt1,0071,005796
Deferred income tax120128107
Minority interest168196127
Other liabilities, total474135
Total liabilities2,1372,2632,045
SHAREHOLDERS EQUITY
Common stock303030
Additional paid-in capital------
Retained earnings (accumulated deficit)1,7381,6561,492
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,7681,6861,522
Total liabilities & shareholders' equity3,9053,9493,567
Total common shares outstanding3.023.023.02
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.